TMF Networks Copyright
Home/Networks/Hospital Quality Improvement Initiative

Thank You and Congratulations

Hospital Quality Improvement Initiative

The Hospital Quality Improvement Contractor (HQIC) program began in September 2020 when the Centers for Medicare & Medicaid Services (CMS) contracted with TMF Health Quality Institute to support qualifying hospitals to improve health care outcomes for rural, medically underserved and vulnerable populations. The overarching goals for the four-year initiative included improving behavioral health outcomes, increasing patient safety and enhancing the quality of care transitions.

TMF and its hospital partners worked together to identify quality improvement opportunities and solutions. HQIC members accessed on-demand educational webinars, topic-specific affinity groups, a robust website with over 2,400 hospital-specific resources and more than 5,800 hours of direct technical assistance.

The 181 hospitals participating in the TMF HQIC program exceeded all of the initiative’s core measure outcome goals, resulting in more than 310 lives saved, over 2,100 patient harms avoided and a savings of more than $43 million in health care costs. [Download our fact sheet (PDF) to learn more.]

The TMF HQIC team is grateful for the opportunity to work with our HQIC hospitals to improve the effectiveness, efficiency, economy and quality of services delivered to patients. Your hard work every day to provide safe and reliable care remains our ongoing inspiration.

As TMF prepares to continue working with CMS on hospital quality improvement, program resources will be available on tmfnetworks.org. Please visit our Partnership for Community Health or Patient and Family Engagement webpages for information, or email HQIC@tmf.org with questions.

These items also available in the Resource Library 
2023 Survey of America’s Current and Future Physicians
The Physicians Foundation’s 2023 Survey of America’s Current and Future Physicians focuses on the state of physician, resident and medical student wellbeing, as well as physician practice environments — and the solutions needed to improve both.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines
On Aug. 22, 2024, the U.S. Food and Drug Administration (FDA) approved and granted emergency use authorization for updated mRNA COVID-19 vaccines, the 2024-2025 formula.
The Public Health Data Strategy
The updated data modernization strategy for 2024-2025 lays out priority work for the next two years to continue to improve our capabilities for early threat detection and real-time monitoring across all levels of public health.
SNAP and WIC recipients in Texas can apply for replacement benefits
The Texas Health and Human Services Commission received federal approval allowing recipients of the Supplemental Nutrition Assistance Program (SNAP) to apply for replacement benefits for food lost or destroyed from Hurricane Beryl. The Special Supplemental Nutrition Program for Women, Infants and Children (WIC) is also replacing food and formula benefits lost during the hurricane.
Medicare coverage is now available for Alzheimer’s drug Kisunla
On July 2, 2024, the Centers for Medicare & Medicaid Services announced that Medicare coverage is now available for Kisunla (donanemab-azbt) following the Food and Drug Administration's (FDA) move to grant traditional approval to the drug that treats people with Alzheimer’s disease. Kisunla joins Leqembi (the brand name for lecanemab-irmb) as the second monoclonal amyloid beta antibody treatment granted traditional FDA approval for Alzheimer’s disease.
1 2 3 4 5Next